Loading organizations...
Key people at Ab Initio Capital.
AB Initio Capital Management LLC is a global investment firm that primarily provides capital to mid to late-stage companies. The firm focuses its strategic investments across the technology, media, and telecommunications (TMT), consumer goods, and healthcare sectors, actively identifying growth opportunities and deploying resources to foster portfolio company development across diverse markets.
Founded by Harry Zhang, AB Initio Capital Management LLC began operations around late 2012. The firm was established with the specific insight to capitalize on emerging industry trends and deliver growth equity to promising ventures, leveraging a deep understanding of relevant market landscapes and investment dynamics.
The firm's clientele comprises growth-oriented companies actively seeking substantial capital and strategic partnerships to facilitate their scaling efforts. AB Initio Capital Management LLC aims to cultivate robust enterprises by supporting their expansion, with a long-term vision of generating significant value through highly focused investments and proactive portfolio management.
Key people at Ab Initio Capital.
Ab Initio Capital has 4 tracked investments across 4 companies. The latest tracked deal is $8.0M Seed in Axoft in October 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2022 | Axoft | $8.0M Seed | The Engine | Boost VC, Collaborative Seed & Growth Partners, Project 11, Speedy Packets Inc., Aibasis, Alumni Ventures, Amino Capital, Blindspot Ventures, Decent Capital, Liquidmetal Ventures, Mintz, Safar Partners, Taihill Venture |
| Aug 22, 2022 | FOMO Pay | $13.0M Series A | TAK Fujishima | Antalpha, HashKey Capital, Republic Capital |
| Nov 29, 2021 | ZhenYun Information Technology | $101.8M Series C | Meituan | Blue Lake Capital, Eastern Bell Capital, Redpoint China, Unicorn Capital Partners, Zhongmi Capital |
| Aug 12, 2021 | Beijing Yuan Xin | $231.5M Series F | — | B Capital Group, CITIC Securities, Future Innovation, HEL VED, Stella Zhou, Index Capital, Kunling Capital, OrbiMed, Sequoia Capital, Springhill, UOB |